Following the breakthrough in the corona virus vaccine and the successful use of MRNA technology, the American pharmaceutical giant is marking a new and challenging target • All details
Medical breakthrough?
Modern company
Photography:
AP
The American pharmaceutical giant Modern, which developed one of the corona vaccines, has launched a major research campaign to develop for the virus, AIDS and influenza viruses, a series of new vaccines based on the same method in which the corona virus is neutralized by genetic engineering of MRNA.
In a conversation with reporters just a week ago, Modern CEO Stefan Bensel declared: “After we were able to develop the vaccine against the corona virus, it encouraged us to move in the direction and develop a more ambitious program to produce three more types of vaccines - against AIDS, influenza and swine virus.
"These are three viruses that are either seasonally renewed, or they are able to fight and evade the body's immune system, and we believe they can be treated more effectively by the new method based on MRNA."
Moderna has announced a huge step in the fight against Corona // Archive photo: Reuters
The hepatitis B vaccine will be called mRNA-1215, while the company has a big plan to similarly develop a double vaccine against the AIDS virus called mRNA-1644 and mRNA-1574.
The company will also develop a vaccine against seasonal flu: flu A and flu B, thus intending to save about a million people a year from dying from flu and AIDS.
Moderna will not only stop these vaccines, and is planning a whole series of developments against dangerous diseases such as bird flu, Epstein-Barr virus, cytomegalovirus, a meta-pneumonic-human virus and a host of bacteria that cause hemophilus influenza pneumonia.
In fact, the new immunization method through MRNA - allows to try to teach the body's immune system to deal with diseases for which no cure has been found to date, and other companies in Europe have begun to explore the possibility inherent in this method even in the face of cancer.
